HOME   Cart(0)   Quotation   About-Us Policy PDFs Standard-List
www.ChineseStandard.net Database: 189759 (19 Oct 2025)

GB/T 12279.1-2024 English PDF

US$1419.00 · In stock
Delivery: <= 8 days. True-PDF full-copy in English will be manually translated and delivered via email.
GB/T 12279.1-2024: Cardiovascular implants - Cardiac valve prostheses - Part 1: General requirements
Status: Valid

GB/T 12279.1: Evolution and historical versions

Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusPDF
GB/T 12279.1-2024English1419 Add to Cart 8 days [Need to translate] Cardiovascular implants - Cardiac valve prostheses - Part 1: General requirements Valid GB/T 12279.1-2024
GB 12279-2008English714 Add to Cart 4 days [Need to translate] Cardiovascular implants -- Cardiac valve prostheses Valid GB 12279-2008
GB 12279-1990English639 Add to Cart 5 days [Need to translate] Cardiac valve prostheses general technical specification Obsolete GB 12279-1990

PDF similar to GB/T 12279.1-2024


Standard similar to GB/T 12279.1-2024

GB/T 39381.1   YY/T 1680   YY/T 1571   GB/T 12279.3   GB/T 12297.2   GB/T 12279.2   

Basic data

Standard ID GB/T 12279.1-2024 (GB/T12279.1-2024)
Description (Translated English) Cardiovascular implants - Cardiac valve prostheses - Part 1: General requirements
Sector / Industry National Standard (Recommended)
Classification of Chinese Standard C45
Classification of International Standard 11.040.40
Word Count Estimation 70,746
Date of Issue 2024-06-29
Date of Implementation 2025-07-01
Older Standard (superseded by this standard) GB 12279-2008
Issuing agency(ies) State Administration for Market Regulation, China National Standardization Administration

GB/T 12279.1-2024: Cardiovascular implants - Cardiac valve prostheses - Part 1: General requirements


---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.040.40 CCSC45 National Standards of People's Republic of China Partially replaces GB 12279-2008 Cardiovascular implantable devices Artificial heart valves Part 1.General requirements Part 1.General requirements Released on 2024-06-29 2025-07-01 Implementation State Administration for Market Regulation The National Standardization Administration issued

Table of Contents

Preface III Introduction V 1 Scope 1 2 Normative references 1 3 Terms and Definitions 2 4 Abbreviations13 5 Basic Requirements 13 6 Device Description 13 7 Design Verification Testing and Analysis/Design Validation 16 Appendix A (Informative) Rationale for the provisions of this document 22 Appendix B (Normative) Packaging 24 Appendix C (Normative) Product labeling, instruction manual and training 25 Appendix D (Normative) Sterilization 28 Appendix E (Normative) Guidance for in vitro testing of pediatric devices 29 Appendix F (Informative) Corrosion Assessment 33 Appendix G (Informative) Assessment of implant thrombosis and hemolytic potential 35 Appendix H (Informative) Guidelines for Characterization of Fluid Dynamic Performance in Steady-State Flow Tests 43 Appendix I (Normative) Durability Test 48 Appendix J (Informative) Fatigue Assessment 54 References 57

Foreword

This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part 1.Structure and drafting rules for standardization documents" Drafting. This document is Part 1 of GB/T 12279 Cardiovascular Implantable Devices - Artificial Heart Valves. GB/T 12279 has been published. The following two parts. --- Part 1.General requirements; --- Part 2.Surgical implantable prosthetic heart valves. This document partially replaces the contents of GB 12279-2008 Cardiovascular Implants - Artificial Heart Valves. Compared with the previous version, in addition to structural adjustments and editorial changes, the main technical changes are as follows. a) Added "Abbreviations" (see Chapter 4); b) Added “Basic Requirements” (see Chapter 5); c) Added “Device Description” (see Chapter 6); d) Added “Design Verification Test and Analysis/Design Confirmation” (see Chapter 7); e) Added the normative appendix “Packaging” (see Appendix B); f) Added the normative appendix “Product labeling, instructions for use and training” (see Appendix C); g) Added the normative appendix “Sterilization” (see Appendix D); h) Added the normative appendix “Guidelines for in vitro testing of pediatric devices” (see Appendix E); i) Added the normative appendix “Durability Test” (see Appendix I). This document is modified to adopt ISO 5840-1.2021 "Cardiovascular implantable devices - Artificial heart valves - Part 1.General requirements". The technical differences between this document and ISO 5840-1.2021 and their reasons are as follows. --- ISO 5840-2 (see 7.1) has been replaced by the normative reference GB/T 12279.2 to adapt to my country's technical conditions and improve the reliability of the product. Operability; --- The normative reference GB/T 16886.1 replaces ISO 10993-1 (see 7.2.3.2) to adapt to my country's technical conditions and provide High operability; --- ISO 11135 (see Appendix D) has been replaced by the normative reference GB 18279.1 to adapt to my country's technical conditions and improve operability. Sex; --- Replaced ISO 11137 (all parts) with the normative reference GB 18280 (all parts) to adapt to my country's technical conditions Improve operability; --- Replaced ISO 11607 (all parts) with the normative reference GB/T 19633 (all parts) to adapt to my country's technical conditions Improve operability; --- The normative reference GB/T 19974 replaces ISO 14937 (see Appendix D) to adapt to my country's technical conditions and improve the reliability of the product. Operability; --- ISO 13485 (see 7.1) has been replaced by the normative reference GB/T 42061 to adapt to my country's technical conditions and improve operability. Sex; --- ISO 14971 (see 6.6) has been replaced by the normative reference GB/T 42062 to adapt to my country's technical conditions and improve operability. Sex; --- Replaced ISO 15223-1 (see C.1.1) with the normative reference YY/T 0466.1 to adapt to my country's technical conditions and improve Operability; --- Replaced ISO 14630 (see 6.1 and 7.2.3.1) with the normative reference YY/T 0640-2016 to adapt to my country's technology Conditions, improve operability; --- Replaced ISO 22442 (all parts) with the normative reference YY/T 0771 (all parts) Medical devices of animal origin to apply Improve operability in response to my country's technical conditions; --- ISO 14160 (see Appendix D) has been replaced with the normative reference YY0970 to adapt to my country's technical conditions and improve operability. Sex; --- Replaced IEC 62366 (all parts) (see 7.2.9) with the normative reference YY/T 1474 to adapt to my country's technical conditions Improve operability; --- The normative reference YY/T 1600 replaced ISO /T S17665-3 (see Appendix D) to adapt to my country's technical conditions and provide High operability; --- Added reference to GB 18278.1 "Sterilization of health care products - Moist heat - Part 1.Development and confirmation of sterilization processes for medical devices" Recognition and routine control requirements (see Chapter 2); --- Added reference to YY/T 1600 "Product families and process categories for moist heat sterilization of medical devices" (see Chapter 2); --- Deleted "Clinical studies" (see 7.4 of ISO 5840-1.2021) and Appendix L (normative) Clinical studies of heart valve replacement devices The research endpoints and related contents should be carefully reviewed to avoid any inconsistency with the Technical Guidelines for Clinical Evaluation of Medical Devices. The following editorial changes were made to this document. --- The informative reference GB/T 16886.4 replaces ISO 10993-4 (see 7.2.2.2), and GB/T 19971 replaces ISO 11139 (see 3.62, 3.63), GB/T 27025 replaced ISO /IEC 17025 (see 7.1, 7.2), YY/T 0663.1 replaced ISO 25539-1 (see 3.11), YY/T 0987.1 replaced ASTMF2053, YY/T 0987.2 replaced ASTMF2052, YY/T 0987.3 replaced ASTMF2119, YY/T 0987.4 replaced ASTMF2182, and YY/T 0987.5 replaced ASTM F2213 (see 7.2.7) and YY/T 1552 replaced ISO 16429 (see F.4); ---Merge the contents of the note to 3.12 into the definition of 3.12; --- Move the content in the note of 3.47 to the note of 7.2.5.2; --- Deleted A.4, A.5 in Appendix A (informative) and the echocardiography protocol section in Appendix G (informative) (see Appendix A and Appendix G). Please note that some of the contents of this document may involve patents. The issuing organization of this document does not assume the responsibility for identifying patents. This document is proposed by the State Food and Drug Administration. This document is under the jurisdiction of the National Technical Committee for Standardization of Surgical Implants and Orthopedic Devices (SAC/TC110). This document was drafted by. China Food and Drug Inspection Institute, National Medical Products Administration Medical Device Technical Evaluation Center, Hangzhou Qi Ming Medical Device Co., Ltd., Shanghai MicroPort Cardiovascular Technology Co., Ltd., and Tianjin Medical Device Quality Supervision and Inspection Center. The main drafters of this document are. Liu Li, Ke Linnan, Wang Chunren, Li Jingli, Shi Xinli, Yang Congcong, Liu Meirong, Zhuang Yaping, Miao Hui, and Zhang Zhenghui. The previous versions of this document and the documents it replaces are as follows. --- First issued as GB 12279-1990 in.1990 and first revised in.2008; ---This is the second revision.

Introduction

This document was prepared by a group of experts involved in the research and development of artificial heart valves. The scope of this document is not covered in some areas. However, this document specifies the test types, provides test methods and/or test equipment. This document is concerned with ensuring maximum compatibility with patients and other device users. The risks associated with users are fully reduced, product quality is ensured, it helps doctors select artificial heart valves, and it is easy to operate during surgery. Standardize the types of in vitro tests, preclinical in vivo evaluations, and reporting of all in vitro tests and preclinical in vivo evaluations, as well as the The process of in vitro testing and preclinical in vivo evaluation is to clarify the process required before the product is put on the market and ensure the subsequent A range of issues can be quickly identified and addressed. Regarding in vitro tests and reports, in addition to basic material mechanical properties, physical properties, chemical properties, and biocompatibility, this document also includes Contains the most important fluid dynamics performance and durability of the system required to achieve artificial heart valves and their implantation. This document does not specify fluid dynamics It does not specify the exact test methods for mechanical properties and durability testing, but provides guidelines for test instruments. As knowledge grows and technology improves in the field of prosthetic heart valve technology, this document may be revised, updated and/or amended. GB/T 12279 Cardiovascular implantable devices - artificial heart valves aims to provide requirements and The test method is planned to consist of three parts. --- Part 1.General requirements. The purpose is to provide general requirements for artificial heart valves. --- Part 2.Surgical implantable artificial heart valves. The purpose is to give specific requirements for surgical implantable artificial heart valves. --- Part 3.Transcatheter implantable artificial heart valve. The purpose is to give the specific Require. This document is used in conjunction with GB/T 12279.2 and ISO 5840-3. Cardiovascular implantable devices Artificial heart valves Part 1.General requirements

1 Scope

This document specifies the general requirements for artificial heart valves intended for implantation in humans and the operating conditions of artificial heart valves. The paper describes an approach to verifying/validating the design and manufacture of artificial heart valves through risk management. Tests and methods, including physical, chemical, biological and mechanical performance tests of artificial heart valves and their materials and components, as well as human Preclinical in vivo evaluation of finished engineered heart valves. This document applies to newly developed and improved artificial heart valves, as well as to implantation of artificial heart valves and determination of the Accessories, packaging and labeling required for the size of the valve. Some of the provisions of this document apply to valves made from devitalized human tissue. This document does not apply to allogeneic valves, tissue-engineered heart valves (i.e. valves intended to regenerate in vivo), and valves designed for implantation in circulatory Ring support devices are designed for heart valves. NOTE. Appendix A explains the rationale for this document.

2 Normative references

The contents of the following documents constitute the essential clauses of this document through normative references in this document. For referenced documents without a date, only the version corresponding to that date applies to this document; for referenced documents without a date, the latest version (including all revised versions) applies. in this document. GB/T 12279.2-2024 Cardiovascular implantable devices - Artificial heart valves - Part 2.Surgical implantable artificial heart valves (GB/T 12279.2-2024,ISO 5840-2.2021,MOD) GB/T 16886.1 Biological evaluation of medical devices Part 1.Evaluation and testing in the risk management process (GB/T 16886.1- 2022,ISO 10993-1.2018,IDT) GB 18278.1 Sterilization of health care products by moist heat Part 1.Development, validation and routine control of sterilization processes for medical devices Request (GB 18278.1-2015, ISO 17665-1.2006, IDT) GB 18279.1 Sterilization of healthcare products with ethylene oxide Part 1.Development, validation and routine control of sterilization processes for medical devices System requirements (GB 18279.1-2015, ISO 11135-1.2007, IDT) GB 18280 (all parts) Radiation sterilization of health care products [ISO 11137 (all parts)] Note. GB 18280.1-2015 Radiation sterilization of health care products Part 1.Development, validation and routine control requirements for sterilization processes for medical devices (ISO 11137-1.2006, IDT); GB 18280.2-2015 Radiation sterilization of health care products Part 2.Establishing the sterilization dose (ISO 11137-2.2006, IDT); GB/T 18280.3-2015 Radiation sterilization of health care products Part 3.Guide to dose measurement (ISO 11137-3.2006, IDT). GB/T 19633 (all parts) Terminally sterilized medical device packaging [ISO 11607 (all parts)] Note. GB/T 19633.1-2015 Terminally sterilized medical device packaging Part 1.Requirements for materials, sterile barrier systems and packaging systems (ISO 11607- 1.2006,IDT); GB/T 19633.2-2015 Terminally sterilized medical device packaging Part 2.Requirements for validation of forming, sealing and assembly processes (ISO 11607-2. 2006, IDT). GB/T 19974 Sterilization of health care products - Characteristics of sterilization factors and development, validation and routine control of sterilization processes for medical devices General requirements (GB/T 19974-2018, ISO 14937.2009, IDT) GB/T 42061 Medical device quality management system for regulatory requirements (GB/T 42061-2022, ISO 13485.

Tips & Frequently Asked Questions:

Question 1: How long will the true-PDF of GB/T 12279.1-2024_English be delivered?

Answer: Upon your order, we will start to translate GB/T 12279.1-2024_English as soon as possible, and keep you informed of the progress. The lead time is typically 5 ~ 8 working days. The lengthier the document the longer the lead time.

Question 2: Can I share the purchased PDF of GB/T 12279.1-2024_English with my colleagues?

Answer: Yes. The purchased PDF of GB/T 12279.1-2024_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.

Question 3: Does the price include tax/VAT?

Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countries

Question 4: Do you accept my currency other than USD?

Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.

Question 5: Should I purchase the latest version GB/T 12279.1-2024?

Answer: Yes. Unless special scenarios such as technical constraints or academic study, you should always prioritize to purchase the latest version GB/T 12279.1-2024 even if the enforcement date is in future. Complying with the latest version means that, by default, it also complies with all the earlier versions, technically.